在体外转录的人工初级微RNA用于抑制B型肝炎病毒在培养细胞中的基因表达
Creanne Shrilall1, Patrick Arbuthnot1, Abdullah Ely1
1Wits/SAMRC Antiviral Gene Therapy Research Unit, Infectious Diseases and Oncology Research Institute (IDORI), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2050, South Africa.
Microorganisms
|March 27, 2025
概括
开发用于慢性乙型肝炎 (hepB) 的新疗法至关重要. 这项研究探讨了在体外转录的基于RNA的人工primiRNAs用于沉默乙型肝炎病毒 (HBV) 基因表达,显示了适度的疗效,但突出了需要改进的领域.
科学领域:
- 分子生物学分子生物学
- 病毒学 病毒学
- 治疗药物的开发开发.
背景情况:
- 慢性乙型肝炎 (hepB) 管理需要改进的治疗方法,因为目前的干预措施的有效性有限.
- 乙型肝炎病毒 (HBV) 预防受到疫苗接种障碍的阻碍,需要新的治疗策略.
- RNA干扰 (RNAi) 为特定基因沉默提供了一条途径,人工初级microRNAs (pri-miRNAs) 显示出对HBV等病毒的承诺.
研究的目的:
- 评估使用体外转录的人造primiRNAs来抑制HBV基因表达的可行性.
- 评估基于RNA的primiRNAs与基于DNA的HBV治疗方法相比的疗效和潜在限制.
主要方法:
- 人工HBV向的pri-miR-31序列使用体外转录合成.
- 这些RNA序列被纳入mRNA,用于传递和评估HBV基因沉默.
- 细胞内处理,病毒复制抑制和非目标效应 (包括干扰素反应) 是特征.
主要成果:
- 在体外转录的人工primiRNAs通过mRNA传递时显示了适度的HBV复制沉默.
- 观察到pri-miRNAs的无效和非特异性细胞内处理.
- 非特异性影响与干扰素反应的刺激有关,表明潜在的目标外活性.
结论:
- 虽然在体外转录的人工primiRNAs显示出抗HBV治疗的潜力,但它们的疗效目前是温和的.
- 优化这些基于RNA的治疗药物的细胞内处理和核输送对于增强抗hepB疗效至关重要.
- 需要进一步的研究来克服处理效率低下,并减轻临床翻译的非目标效应.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:15Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
02:30siRNA - Small Interfering RNAs
16.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.4K
01:23RNA Interference
25.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.8K